Sofinnova Investments’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-981,928
| Closed | -$2.98M | – | 65 |
|
|
2022
Q2 | $2.98M | Sell |
981,928
-499,291
| -34% | -$1.51M | 0.25% | 45 |
|
|
2022
Q1 | $10.1M | Sell |
1,481,219
-101,558
| -6% | -$690K | 0.76% | 28 |
|
|
2021
Q4 | $13.2M | Buy |
1,582,777
+945,430
| +148% | +$7.89M | 0.77% | 33 |
|
|
2021
Q3 | $4.74M | Buy |
637,347
+12,591
| +2% | +$93.5K | 0.28% | 51 |
|
|
2021
Q2 | $4.25M | Buy |
624,756
+112,934
| +22% | +$768K | 0.24% | 51 |
|
|
2021
Q1 | $5.26M | Sell |
511,822
-413,458
| -45% | -$4.25M | 0.32% | 45 |
|
|
2020
Q4 | $6.48M | Buy |
+925,280
| New | +$6.48M | 0.39% | 42 |
|